Skip to main content
Premium Trial:

Request an Annual Quote

Edward Koval, Mark Adams, James Aswell, Bill Rutter, Stelios Papadopoulos

Premium

Variagenics of Cambridge, Mass., has promoted Edward Koval, previously senior director of business development, to vice president of corporate and strategic development and Mark Adams, previously senior director, to vice president of bioinformatics.

The company has also hired James Aswell as senior director of diagnostics, a newly created position. Aswell was formerly senior staff scientist at Bayer Diagnostics.

Bill Rutter and Stelios Papadopoulos have been appointed to the board of directors of San Diego-based Structural GenomiX, increasing the board to eight members.

Rutter is a founder and chairman emeritus of Chiron and also a founder of Prospect Genomics, which was recently acquired by Structural GenomiX.

Papadopoulos is a managing director in the investment banking division at SG Cowen.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.